At the time of the first visit all the RA patients in both treatment groups had comparable frequencies of IgD+CD27- naïve B cells, IgD+CD27+ pre-switch memory B cells and IgD-CD27+ post-switch B cells. This evidence concerns the gene CD27 and rheumatoid arthritis.